Preliminary Draft

See our two concurrent peptides and oligonucleotides tracks: click on the following buttons

TRACK ON OLIGOS

9:00 – 9:10

Welcome

Detlef Rethage & Kathryn Ackley

9:10 – 10:10

Workshop on Discovery
Oligonucleotide Drug Discovery and Optimization: Case Studies from 15 Years of LNA Drug Design

Christoph Rosenbohm
Roche Denmark

10:10 – 10:40

Presentation
Tackling the Challenge of Delivery for Antisense Oligonucleotides

Suzan Hammond
University of Oxford

10:40 – 11:00

COFFEE – POSTERS & EXHIBITION

11:00 – 12:00

Workshop on Manufacturing
Manufacturing Oligonucleotide Drugs

Thomas Rupp
Thomas Rupp Consulting

12:00 – 12:20

Sponsor Presentation
Mixing Method Comparison for Oligonucleotide Synthesis

Hanson Chang
CS BIO

12:20 – 13:30

LUNCH – POSTERS & EXHIBITION

13:30 – 14:30

Workshop on Analytical
Analytical Analysis of Oligonucleotide APIs

Ed Huber
Nitto Denko Avecia

14:30 – 14:50

Sponsor Presentation
Title & Company TBC

14:50 – 15:30

Roundtable
Oligo Drug Development Round Table

Moderator:
Arthur Krieg & Kathryn Ackley

15:30 – 16:00

COFFEE – POSTERS & EXHIBITION

16:00 – 16:45

Market Trends
Market Overview: Developments of an Advancing Oligonucleotide Therapeutics Pipeline

Detlef Rethage
Rethage Advisors

16:45 – 17:30

Keynote Lecture
Regulatory Challenges in Oligonucleotide Drug Development using the Example of BC 007, neutralizer of Pathogenic Autoantibodies against G Protein-Coupled Receptors for Autoimmune-Associated Heart Failure

Annekathrin Haberland
Berlin Cures

17:30 – 17:40

CONCLUSIONS OF THE DAY

17:40 – 19:00

NETWORKING COCKTAIL RECEPTION – POSTERS & EXHIBITION

20:00 – 22:30

NETWORKING DINNER @ La casa dei ciliegi (walking distance)

For registered attendees only

8:50 – 9:00

Welcome

Detlef Rethage & Kathryn Ackley

9:00 – 9:45

Keynote Lecture
Mechanisms and Therapeutic Applications of Immune Stimulatory CpG DNA

Arthur M. Krieg
Checkmate Pharmaceuticals

9:45 – 10:15

Presentation
Targeting Dynamin 2 in Centronuclear Myopathies with Antisense Oligonucleotides: Pathogenesis and Therapies

Belinda Cowling
Dynacure SAS

10:15 – 10:35

Sponsor Presentation
Title TBC

Speaker TBC
emp Biotech

10:35 – 11:15

COFFEE – POSTERS & EXHIBITION

11:15 – 12:00

Keynote Lecture
LNA Building Blocks for Therapeutic Oligonucleotides

Jesper Wengel
University of Southern Denmark

12:00 – 12:30

Presentation
CMC Challenges Associated with Oligonucleotide Products for Local Administration

Bianca Mathee
ProQR Therapeutics N.V.

12:30 – 13:45

LUNCH – POSTERS & EXHIBITION

13:45 – 14:15

Presentation
Multitargeting Spherical Nucleic Acids: Advantages & Applications

Matthias Schroff
Exicure

14:15 – 14:45

Panel Discussion
CDMO News Flashlight

Moderator:
Detlef Rethage

14:45 – 15:05

Sponsor Presentation
Title & Company TBC

 

15:05 – 15:35

Presentation
Managing the Drug Sponsor-CMO Relationship

Thomas Rupp
Thomas Rupp consulting

15:35 – 16:00

Presentation
Oligonucleotide Manufacturing Capacity of CMO’s. How Much is Enough?

Detlef Rethage
Rethage Advisors

16:00 – 16:15

Final Discussion & Symposium Conclusion

TRACK ON PEPTIDES

9:00 – 9:10

Welcome

Fernando Albericio & Annamaria Papini

9:10 – 9:55

Keynote Lecture
Peptide Therapeutics Market Trends

Frank Otto Gombert
GPRS – Gombert Pharma Research Solutions

9:55 – 10:25

Presentation
How to Manage Oral Bioavailability for Cyclic Peptides

Thomas Vorherr
Novartis

10:25 – 11:00

COFFEE – POSTERS & EXHIBITION

11:00 – 12:00

Workshop on Delivery
The Challenge of Peptide Drug Delivery

Annamaria Papini & Elisabetta Bianchi

12:00 – 12:20

Sponsor Presentation
Challenges in Peptide & Oligonucleotide Formulation: An Integrated CDMO Perspective

Fabio Stevanon
CordenPharma

12:20 – 13:30

LUNCH – POSTERS & EXHIBITION

13:30 – 14:15

Keynote Lecture
Title & Company TBC

14:15 – 14:45

Presentation
Synthesis of Linaclotide Peptide as an Example of a Complex Peptide for Commercial Large Scale Production-Case Study for Small and Commercial Production

Daniel Bourgin
Dr. Reddy’s CPS

14:45 – 15:15

Presentation
Production of Peptide via Recombinant Approach. Advantages and Disadvantages from the Economic, Quality and Regulatory Point of View

Piera Fonte
Olon

15:15 – 15:35

Sponsor Presentation
Title & Company TBC

15:35 – 16:00

COFFEE – POSTERS & EXHIBITION

16:00 – 17:00

Workshop on Manufacturing
Title TBC

Fernando Albericio
University of Barcelona

17:00 – 17:20

Sponsor Presentation
Fmoc-Cys(Msbh) – A Sophisticated Building Block for Cysteine-Rich Peptides. A Journey from Discovery to Large Scale Production

Markus Weishaupt
Iris Biotech

17:20 – 19:00

NETWORKING COCKTAIL RECEPTION – POSTERS & EXHIBITION

20:00 – 22:30

NETWORKING DINNER @ La casa dei ciliegi (walking distance)

For registered attendees only

8:50 – 9:00

Welcome

Fernando Albericio & Annamaria Papini

9:00 – 9:45

Keynote Lecture
Radiolabelled Peptides for Cancer Imaging and Therapy: Past-Present-Future

Melpomeni Fani
University Hospital Basel

9:45 – 10:15

Panel Discussion
CDMO News Flashlight

10:15 – 10:35

Sponsor Presentation
Title TBC

Speaker TBC
Bachem

10:35 – 11:00

COFFEE – POSTERS & EXHIBITION

12:00 – 12:20

Workshop on Analysis
Data Integrity and Computer System Validation –  Trends and Methodologies

Stefano Carganico
Pharma Quality Europe

12:20 – 12:40

Sponsor Presentation
Are All Resins in Fact the Same?

Alessandra Basso
Purolite

12:40 – 13:45

LUNCH – POSTERS & EXHIBITION

13:45 – 14:15

Presentation
Overcoming Challenges to Effect Best Case Technology Transfer

Ewa Kowalska
Ipsen Manufacturing

14:15 – 14:45

Presentation
Appropriate Screening for ADME Properties and Pseudo-Allergic Reactions Is Key to Success in Peptide Drug Discovery: a Case Study

Elisabetta Bianchi
IRBM

14:45 – 15:05

Sponsor Presentation
Cost Effective Peptide Purification via ZEOsphere DRP Mixed-Mode Chromatography

Victoria Custodis
Zeochem

15:05 – 15:35

Presentation
Specific Glycosylation Techniques for Efficient Protein Therapeutics

Anna Maria Papini
University of Florence

15:35 – 16:05

Presentation
Cyclic Peptides With Therapeutic Activity

Fernando Albericio
University of Barcelona

16:05 – 16:20

Final Discussion & Symposium Conclusion